homotrimeric, matricellular glycoprotein that regulates cell proliferation, migration and cell death in a variety of physiological and pathological settings, including wound healing, inflammation, angiogenesis and neoplasia. TSP-1 has been described to induce apoptosis through caspase-dependent and -independent mechanisms. For HNSCC, TSP-1 was found to be down-regulated in patient samples using high-throughput protein microarray techniques [6] .
Our preliminary evidence indicated that c-MYC depletion potentiates cisplatin-induced apoptosis in HNSCC at least partly through up-regulation of TSP-1. Stable c-MYC gene silencing by short hairpin RNA (shRNA) approach resulted in a marked up-regulation of endogenous TSP-1 expression and a significant increase in generation of apoptosis following cisplatin treatment in a commonly used HNSCC cell line, SCC-25 ( Figure 1A and B) . In the present study, we used two shRNA-expressing plasmids with different target sequences (shMYC-1/-2) to exclude off-target effects. Furthermore, as shown in Figure 1C , when we resuppressed TSP-1 expression by small interfering RNA (siRNA) technique in the c-MYCdown-regulated SCC-25 cells, the sensitization of cells to cisplatin-induced apoptosis was markedly abolished. We used stable transfectants expressing shMYC-2 to carry out this assay due to its higher efficacy of c-MYC knockdown than the other transfectant shMYC-1 in SCC-25 cells, as determined in Figure  1A . TSP-1 induction by c-MYC knockdown and resuppression by siRNA approach were confirmed in Figure 1D .
Collectively, our data presented here strongly indicate a therapeutic potential of targeting c-MYC-TSP-1 axis in HNSCC. It would be of great interest to further investigate the role of c-MYC-TSP-1 pathway in the pathogenesis of HNSCC and other human malignancies. 
